CARLSBAD, Calif., Dec. 2, 2021 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will
host a virtual investor day on Thursday,
December 9th at 11:00 a.m.
Eastern Time. The company will provide an overview of its
strategy, plans, and progress to bring its most advanced programs
to market and achieve commercial success as well as highlight key
technology advances. The webcast is expected to last approximately
2.5 hours.
Interested parties may access the webcast at
https://www.ionispharma.com/investor-day. A replay will be
available for a limited time at the same address.
About Ionis Pharmaceuticals
For more than 30 years,
Ionis has been the leader in RNA-targeted therapy, pioneering new
markets and changing standards of care with its novel antisense
technology. Ionis currently has three marketed medicines and a
premier late-stage pipeline highlighted by industry-leading
neurological and cardiometabolic franchises. Our scientific
innovation began and continues with the knowledge that sick people
depend on us, which fuels our vision of becoming one of the most
successful biotechnology companies.
To learn more about Ionis visit www.ionispharma.com and
follow us on twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-virtual-investor-day-event-301436652.html
SOURCE Ionis Pharmaceuticals, Inc.